What is a multidisciplinary tumor board and should my Testicular Cancer case be presented

Testicular CancerJune 4, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Multidisciplinary Tumor Boards for Testicular Cancer

What Is a Multidisciplinary Tumor Board?

A multidisciplinary tumor board (often called a "tumor board" or "cancer conference") is a meeting where different cancer specialists come together to discuss individual patient cases. Think of it as a team huddle where experts from different medical fields review your medical information and collaborate on treatment recommendations.

Who typically participates:

  • Medical oncologists (chemotherapy specialists)
  • Surgical oncologists (cancer surgeons)
  • Radiation oncologists (radiation therapy specialists)
  • Urologists (specialists in testicular/urinary system cancers)
  • Pathologists (specialists who analyze tissue samples)
  • Radiologists (imaging specialists)
  • Nurses and other support staff
  • Sometimes fertility specialists or other relevant experts

Why Tumor Boards Matter for Testicular Cancer

According to the NCCN Guidelines for Testicular Cancer, multidisciplinary care is strongly emphasized because testicular cancer treatment often requires coordinated decisions across multiple specialties. Here's why this matters for your case:

Complex decision-making: Testicular cancer treatment involves:

  • Deciding between surgery options (radical orchiectomy vs. testis-sparing surgery)
  • Determining if chemotherapy is needed
  • Planning radiation therapy if appropriate
  • Managing post-chemotherapy residual masses (remaining tumors after treatment)
  • Coordinating fertility preservation before treatment

Better outcomes: The NCCN Guidelines specifically state that "close and regular communication among all providers across disciplines is essential" and recommend that "brain tumor board or multidisciplinary clinic care models are strongly recommended."

Should Your Case Be Presented?

YES—your testicular cancer case should be presented to a tumor board, especially if:

✅ You have metastatic disease (cancer that has spread beyond the testicle) ✅ You're facing treatment decisions (surgery, chemotherapy, radiation) ✅ Your case is complex or unusual ✅ You have residual masses after chemotherapy ✅ You're considering clinical trials ✅ You want a second opinion on your treatment plan ✅ Your tumor markers are elevated or behaving unexpectedly

Questions to ask your healthcare team:

  1. "Will my case be presented to a multidisciplinary tumor board?" This ensures multiple experts review your specific situation.

  2. "Who will be on the tumor board discussing my case?" You want to know that urologists, oncologists, and other relevant specialists are involved.

  3. "Can I attend the tumor board discussion or receive a summary of their recommendations?" Some centers allow patient participation or provide detailed summaries.

  4. "If my case isn't automatically presented, can we request a tumor board review?" You have the right to ask for this.

  5. "Are there any clinical trials the tumor board recommends I consider?" The NCCN Guidelines note that "offering patients the option of participation in a clinical trial is strongly encouraged."

What to Expect

The tumor board will typically:

  • Review your pathology report (tissue diagnosis)
  • Examine your imaging (CT scans, PET scans, ultrasounds)
  • Discuss your tumor markers (AFP, beta-hCG, LDH)
  • Consider your overall health and risk factors
  • Recommend a coordinated treatment plan
  • Identify potential clinical trials

Special Considerations for Testicular Cancer

According to the NCCN Guidelines, the Panel specifically recommends:

  • Referral to high-volume centers for complex cases, especially for surgical resection of residual masses after chemotherapy
  • Fertility counseling before treatment (sperm banking should be discussed)
  • Coordination between specialists for managing long-term side effects

The guidelines emphasize that "patients with recurrent seminoma or nonseminoma be treated at centers with expertise in the management of this disease," which often means centers with active tumor boards.

Taking Action

If you haven't already:

  1. Ask your primary oncologist or urologist if your case will be presented to a tumor board
  2. Request a tumor board review if it hasn't been scheduled
  3. Ask for a written summary of the board's recommendations
  4. Bring this summary to your next appointment to discuss implementation

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.


Sources cited:

  • NCCN Guidelines for Testicular Cancer (Version 1.2026)
  • American Society of Clinical Oncology (ASCO) principles of multidisciplinary care

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: